PedAM
Pediatric Disease Annotations & Medicines
| Disease | dystonia |
| Phenotype | C0007789|cerebral palsy |
| Sentences | 6 |
| PubMedID- 25368640 | Botulinum toxin is commonly used to reduce spasticity and dystonia in children with cerebral palsy. |
| PubMedID- 26038278 | Deep anterior cerebellar stimulation reduces symptoms of secondary dystonia in patients with cerebral palsy treated due to spasticity. |
| PubMedID- 21830852 | Background: spasticity and dystonia in children with cerebral palsy has been treated with intrathecal baclofen therapy (itb) at the royal children's hospital, melbourne, australia (rch) since 1999. |
| PubMedID- 25084089 | Intrathecal baclofen (itb) is a reversible treatment that reduces muscle tone to ameliorate spasticity and dystonia in patients with cerebral palsy (cp). |
| PubMedID- 26068444 | On the other hand, the bad scale was developed to assess, through observation-based examinations, varied functional limitations due to dystonia in persons with cerebral palsy and traumatic brain injury, and it is not related to any specific task [10]. |
| PubMedID- 21310336 | A paucity of information exists regarding medications to treat dystonia in children with cerebral palsy. |
Page: 1